Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
← catalyst calendarNCT07190807 · readout ≤ 468 d
Sponsored by Boston Scientific Corporation (industry) · BSX — their whole pipeline →.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
70estimated
Sites
7
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-11-07 | actual | When the study began enrolling |
| Primary completion | Nov 2027 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | May 2029 | estimated | The whole study's end, after follow-up |
| First posted | 2025-09-24 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-11 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Chronic Pain
- Intractable Pain
- Low Back Pain
- Chronic Low-back Pain
- Chronic Leg Pain
- Leg Pain
Intervention
- Device: Boston Scientific WaveWriter Alpha™ SCS Systems
Primary outcome
what the primary-completion date above is the date OFTargeted Pain Responder Rate
measured 3 months post-activation
Permalink · BSX's whole pipeline · Catalyst calendar · Every registered study · What changed